Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

oleh Kolberg Hans-Cristian, Colleoni Marco, Demetriou Georgia Savva, Santi Patricia, Tesch Hans, Fujiwara Yasuhiro, Tomašević Zorica, Hanes Vladimir
Terbitan: 2020